Codex Committee on Residues of Veterinary Drugs in Foods (CCRVDF)
| FAO/WHO ID No: | CX-730 |
| Reference: | CX/RVDF |
| Terms of Reference: | (a) to determine priorities for the consideration of residues of veterinary drugs in foods; (b) to recommend maximum levels of such substances; (c) to develop codes of practice as may be required; and, (d) to consider methods of sampling and analysis for the determination of veterinary drug residues in foods. |
| Status: | Active |
| Host: | United States of America |
Related Circular Letters
| Code | Issued | Title | Deadline | EN | FR | ES | AR | ZH | RU |
|---|---|---|---|---|---|---|---|---|---|
| CL 2010/47-RVDF | 08/10 | Distribution of the Report of the Nineteenth Session of the Codex Committee on: PART C . REQUEST FOR COMMENTS | 29/11/2011 |  | | |  | | |
| CL 2010/50-RVDF | 08/10 | Request for comments/information on Priority List of Veterinary Drugs Requiring Evaluation or Reevaluation | 14/12/2011 | | | | | | |
| CL 2012/11-RVDF | 04/12 | Distribution of the Report of the Twentieth Session of the Codex Committee on Residues of Veterinary Drugs in Foods (REP12/RVDF) | 14/06/2012 | | | | | | |
| CL 2012/23-RVDF | 07/12 | Request for comments on:Part A: Comments at Step 6 on the draft Maximum Residue Levels (MRLs) for Monepantel (sheep tissues)Part B: Comments at Step 3 on the proposed draft Risk Management Recommendations for Chloramphenicol and Malachite green (N10-2012) | 29/05/2013 | | | | | | |
| CL 2012/30-RVDF | 09/12 | Request for comments/information on priority list of veterinary drugs for evaluation or reevaluation by JECFA | 29/05/2013 | | | | | | |
| CL 2013/26-RVDF | 08/13 | Distribution of the Report of the Twenty-First Session of the Codex Committee on Residues of Veterinary Drugs in Foods (REP14/RVDF) | 29/03/2014 | | | | | | |
| CL 2014/03-RVDF | 12/13 | Request for Comments/Information on Priority List of Veterinary Drugs for Evaluation or Reevaluation by JECFA | 14/12/2014 | | | | | | |
| CL 2014/09-RVDF | 02/14 | Request for Revision/Information to the Database on Countries' Needs for MRLs | 29/06/2014 | | | | | | |
| CL 2015/18-RVDF | 06/15 | Request for comments / information on priority list of veterinary drugs for evaluation or reevaluation by JECFA | 15/08/2016 | | | | | | |
| CL 2015/14-RVDF | 05/15 | PART B – Request for Comments at step 3: Proposed Draft Risk Management Recommendation for Gentian Violet | 31/07/2016 | | | | | | |
| CL 2016/38/OCS-RVDF | 10/16 | Request for comments at Step 5/8 on the proposed draft MRLs for lasalocid sodium, ivermectin and teflubenzuron | 15/06/2017 | | | | | | |
| CL 2016/39/OCS-RVDF | 10/16 | Request for comments at Step 5 on the proposed draft RMR for gentian violet | 15/06/2017 | | | | | | |
| CL 2016/42-RVDF | 12/16 | Request for Revision/Information to the Database on Countries’ Needs for MRLs | 15/12/2017 | | | | | | |
| CL 2016/41-RVDF | 12/16 | Request for Comments/Information on Priority List of Veterinary Drugs for Evaluation or Reevaluation by JECFA | 15/02/2018 | | | | | | |
| CL 2017/72/OCS-RVDF | 08/17 | Request for comments at Step 6 on the draft RMR for gentian violet | 30/01/2018 | | | | | | |
| CL 2017/85/OCS-RVDF | 12/17 | Request for comments at Step 3 on the proposed draft MRLs for amoxicillin (finfish fillet, muscle); ampicillin (finfish fillet, muscle); flumethrin (honey), lufenuron (salmon and trout fillet), monepantel (cattle fat, kidney, liver, muscle) | 15/03/2018 | | | | | | |
| CL 2018/36/OCS-RVDF | 05/18 | Request for comments at Step 8 on the draft Risk Management Recommendation for Gentian Violet | 10/06/2018 | | | | | | |
| CL 2018/37/OCS-RVDF | 05/18 | Request for comments at Step 5/8 on the proposed draft maximum residue limits for veterinary drugs: Amoxicillin (finfish fillet, muscle); Ampicillin (finfish fillet, muscle); Alufenuron (salmon and trout fillet) and Monepantel (cattle fat, kidney, liver, muscle) | 10/06/2018 | | | | | | |
| CL 2018/38/OCS-RVDF | 05/18 | Request for comments at Step 5 on the proposed draft maximum residue limit for flumethrin (honey) | 10/06/2018 | | | | | | |
| CL 2020/17(REV1)-RVDF | 02/20 | Request for comments on MRLs for veterinary drugs tissues | 28/02/2021 | | | | | | |
| CL 2020/18(REV1)-RVDF | 02/20 | Request for comments on the priority list of veterinary drugs for evaluation by JECFA | 28/02/2021 | | | | | | |
| CL 2020/42(REV1)-RVDF | 07/20 | Request for comments / information on the: (i) approach for the extrapolation of MRLs for veterinary drugs to one or more species and (ii) proposals for MRLs based on the approach proposed for extrapolation of MRLs to one or more species | 28/02/2021 | | | | | | |
| CL 2021/02/OCS-RVDF | 0/ | Request for comments on the recommendations for the further steps on the use and maintenance of the database on countries’ needs for maximum residue limits for veterinary drugs in foods | 30/04/2021 | | | | | | |
| CL 2021/05/OCS-RVDF | 01/21 | Request for comments on the principles and procedure for the parallel review of a new veterinary drug by JECFA and national regulatory agencies | 30/04/2021 | | | | | | |
| CL 2021/06/OCS-RVDF | 04/21 | Request for comments on the recommendations for edible offal and other animal tissues of relevance for the purpose of harmonization and elaboration of maximum residue limits for compounds with dual uses | 05/06/2021 | | | | | | |
| CL 2021/75-RVDF | 10/21 | Request for comments on texts going for adoption by CAC (Steps 5, 5/8 and 8) – CCRVDF | 05/11/2021 | | | | | | |
| CL 2021/98-RVDF | 12/21 | Request for comments on proposed MRLs for veterinary drugs extrapolated to one or more species | 25/03/2022 | | | | | | |
| CL 2022/71-RVDF | 0/ | Request for comments at Steps 3 and 6 on MRLs for veterinary drugs | 05/01/2023 | | | | | | |
| CL 2022/72-RVDF | 0/ | Request for comments/information on the priority list of veterinary drugs for evaluation or re-evaluation by JECFA | 10/01/2023 | | | | | | |
| CL 2022/76-RVDF | 0/ | Request for comments on the extrapolation of MRLs for veterinary drugs to one or more species | 30/01/2023 | | | | | | |
| CL 2022/77-RVDF | 12/22 | Request for comments on criteria and procedures for the establishment of action levels for unintended and unavoidable carryover of veterinary drugs from feed to food of animal origin | 30/01/2023 | | | | | | |
| CL 2022/78-RVDF | 12/22 | Request for comments on the recommendations arising from the Joint CCPR/CCRVDF EWG | 30/01/2023 | | | | | | |
| CL 2022/79-RVDF | 0/ | Request for comments on conclusions/recommendations concerning issues pertaining to harmonization of edible offal | 0/0/ | | | | | | |
| CL 2024/65-RVDF | 07/24 | Request for comments on MRLs for veterinary drugs in foods | 30/09/2024 | | | | | | |
| CL 2024/66-RVDF | 07/24 | Request for comments/information on the priority list of veterinary drugs for evaluation or re-evaluation by JECFA | 30/09/2024 | | | | | | |
| CL 2024/67-RVDF | 07/24 | Request for comments on extrapolation of MRLs for veterinary drugs to one or more species | 30/09/2024 | | | | | | |
| CL 2024/68-RVDF | 08/24 | Request for comments on criteria and procedures for the establishment of action levels for veterinary drugs in food of animal origin resulting from unavoidable and unintentional veterinary drug carry-over in non-target animal feed | 05/10/2024 | | | | | | |